From the Announcement can somebody please tell what this actually means in terms going forward.
“
The company says the licensing agreement remains in place, requiring Mylan to continue to take “commercially reasonable efforts to develop TPM-daptomycin, not to sell a generic daptomycin and to pay royalties to Phosphagencis on commercial sales.
“Phosphagenics may be required to enforce its remaining rights to require Mylan to act in line with requirements of the licencing agreement,” the company says.
- Forums
- ASX - By Stock
- Ann: Phosphagenics Arbitration Award Issued
From the Announcement can somebody please tell what this...
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add POH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
POH (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online